Counting the top ten players in global cardiovascular medical devices
According to a study by EvaluateMedTech, Medtronic will continue to lead the cardiovascular market in the coming years. Medtronic expects global sales to reach $11.1 billion in 2020 and will maintain a significant gap with the second largest company, St. Jude Medical . The top five companies will also have Boston Science, Abbott and Edward. The report does not consider Medtronic's acquisition of Kehui Medical, and this acquisition will enhance Medtronic's dominant position in the cardiovascular market. If you add Kehui Medical (ranked 11th on this list), Medtronic's global sales will reach 12.6 billion US dollars in 2020, accounting for 22% of the global market share. Since GE and Philips did not publish sales data for their cardiovascular sector, they were not taken into account. Top 10 global cardiovascular companies Medtronic Medtronic was founded in 1949 by Earl E. Bakken and Palmer J. Hermundslie. Global 500 Group. Medtronic produced the first portable external cardiac pacemaker in 1957 and in 1960 produced the first reliable implantable cardiac pacing system. This laid the foundation for Medtronic's global pacing technology leader. Today, Medtronic has become the world's leading medical technology company, providing life-long solutions for patients with chronic conditions. Medtronic is headquartered in Minneapolis, Minnesota, USA. Committed to providing treatment, diagnosis and monitoring programs for patients with cardiovascular, neurological, diabetes, spinal diseases and ENT diseases. Medtronic started with a pacemaker and has diversified over the past few decades. They used the power of implantable pacemakers to develop neural stimulation techniques and developed treatments for vascular diseases. Ten years ago, they began to diversify into multiple therapeutic areas such as the spine and diabetes. Medtronic began operations in China in 1989, and in 1996 it officially established an office and began to establish a factory. Medtronic’s sales in China account for only over 1% of the company’s total sales, but it has been growing at a rapid rate of 40% over the past 10 years. At the press conference at the end of the year, Medtronic executives announced that in the future, the business in China will expand in both breadth and depth, and the Chinese market should be developed into the second largest market outside the United States. At present, Medtronic's sales in China are mainly agents. Medtronic China has more than 500 dealers; it is divided into 7 major business units, each with independent dealers. Li Bingrong, president of Greater China, explained that there are more than 500 dealers across the country because there is no power to operate across the country. It is currently necessary to work with these distributors. The future development direction is integration, combining small ones into large distributors; in the future, we must strengthen our direct sales force. St. Jude St. Jude Medical is a medical instrument company headquartered in St. Paul, Minnesota. Since 1976, St. Jude Medical Equipment has been a pioneer in cardiovascular medical technology. St. Jude Medical Equipment has expanded its product line through independent innovation and strategic acquisitions, and has grown from being a heart valve manufacturer to a global leader in this field. The company is currently focusing on developing relevant medical technologies for patients with heart disease, neurological diseases and chronic pain. As a public company listed on the New York Stock Exchange, our revenue reached $4.6 billion. St. Jude's products are found all over the world, but China has always been an important market for St. Jude. Because of this, as early as 1982, St. Jude's mechanical heart valve was first used in Shanghai Ruijin Hospital. Today, St. Jude's branches are also located throughout the country, including Shanghai, Beijing, Guangzhou and Hong Kong. Abbott is now acquiring St. Jude for $25 billion, and St. Jude will be included in Abbott’s cardiovascular device division. So Abbott will surpass Boston Science, stay in second place, and catch up with Medtronic, the gap is greatly reduced. The market structure of this segment of cardiovascular medical devices will change dramatically. Lactic Acid 80% Lactic Acid 80%,Food Grade Lactic Acid 80%,80% Liquid Lactic Acid,High Quality Lactic Acid 80% SHANDONG BAISHENG BIOTECHNOLOGY CO., LTD , https://www.baishengbioproducts.com
